| Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product (NCT05282940) | Laboratorios Andromaco S.A. | 2022-02-26 |
| A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects (NCT05225974) | The Affiliated Hospital of Qingdao University | 2021-07-16 |
| Bioequivalence of Ezetimibe Tablets in Healthy Subjects (NCT04814589) | Cao Yu | 2021-03-13 |
| Bioequivalence Study Between Temozolomide Oral Suspension (Ped-TMZ) and Temodal® Capsules (NCT04467346) | Orphelia Pharma | 2020-09-25 |
| Bioequivalence of Extended Release Nifedipine Tablets in Healthy Chinese Subjects (NCT04438720) | Cao Yu | 2020-06-25 |
| Bioequivalence of Azathioprine Suspension 10 mg/mL (Jayempi) Versus Azathioprine Tablet 50mg (Imurek®) (NCT03930264) | Nova Laboratories Limited | 2019-04-11 |
| Bioequivalence Evaluation of Two Fixed-dose Combination of Lisinopril 10mg/Levamlodipine Besylate 5mg in Healthy Chinese Subjects (NCT04885660) | The Affiliated Hospital of Qingdao University | 2018-10-12 |
| Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir (NCT03631316) | Luis Eduardo Morales Buenrostro | 2018-03-01 |
| Bioequivalence Study of Vigabatrin ORPHELIA Pharma 500mg Soluble Tablets and SabrilTM 500mg Granules for Oral Administration (NCT04468282) | Orphelia Pharma | 2017-04-04 |
| A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets Under Fasting Conditions (NCT01405157) | Pfizer | 2012-01-01 |
| A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets (NCT01405131) | Pfizer | 2012-01-01 |
| A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions (NCT01405170) | Pfizer | 2011-10-14 |
| A Study To Determine Bioequivalence Between The Commercial Femulen Tablets And A Reformulation Of Femulen Tablets In Healthy Female Subjects (NCT01359163) | Pfizer | 2011-06-01 |
| Bioequivalence Study in Healthy Subjects, 2*5 mg Tablets Rivaroxaban Versus 1*10 mg Tablet Rivaroxaban (NCT01436526) | Bayer | 2009-08-01 |
| Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food Effect (NCT00807118) | Pfizer | 2008-10-01 |
| Bioequivalence of Rebamipide in Korean (NCT00997789) | Chonnam National University Hospital | 2008-03-01 |
| Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women. (NCT00709189) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-05-01 |
| Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women. (NCT00709644) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-04-01 |
| Fed Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Tablets (NCT00658541) | Mutual Pharmaceutical Company, Inc. | 2004-05-01 |
| Fasted Bioequivalence Study of Primidone Tablets and Mysoline Tablets (NCT00685165) | Mutual Pharmaceutical Company, Inc. | 2004-05-01 |
| Fasted Bioavailability Study of Cilostazol Tablets, 100 mg (NCT00684762) | Mutual Pharmaceutical Company, Inc. | 2004-03-01 |
| Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects (NCT00648544) | Mylan Pharmaceuticals Inc | 2003-07-01 |
| Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects (NCT00650221) | Mylan Pharmaceuticals Inc | 2003-06-01 |